1/ @PfizerBioNTech COVID-19 vaccin
Het #pfizer #biontech onderzoeksprotocol:
cdn.pfizer.com/pfizercom/2020…
@hugodejonge @MinPres
2/ @PfizerBioNTech COVID-19 vaccin
Verwachte einddatum studie: 31 januari 2023
Experimentele groep: BNT162b1
clinicaltrials.gov/ct2/show/NCT04…
@hugodejonge @MinPres
3/ @PfizerBioNTech COVID-19 Vaccin
Deelnemers studie: gezonde mensen
cdn.pfizer.com/pfizercom/2020…
@hugodejonge @MinPres
4/ @PfizerBioNTech COVID-19 vaccin
Uitgesloten deelnemers studie: andere medische of psychiatrische aandoening.
cdn.pfizer.com/pfizercom/2020…
@hugodejonge @MinPres
5/ Hoe weet @hugodejonge dat de coronavaccins van @PfizerBioNTech werkzaam en veilig zijn voor ongezonde, kwetsbare mensen?
Hoe weet @hugodejonge dat de @PfizerBioNTech ernstige ziekte en sterfte onder de kwetsbare risicogroep kan voorkomen?
@MinPres
6/ Heeft @hugodejonge begrip voor deze vragen?
@MinPres
#ParlementaireEnquête
7/ ‘No mRNA immunotherapy has been approved, and none may ever be approved. mRNA drug development has substantial clinical development and regulatory risks due to the novel and unprecedented nature of this new category of therapeutics.’
sec.gov/Archives/edgar…
@hugodejonge
8/ Death
‘As with most biological products, use of our product candidates could be associated with side effects or adverse events which can vary in severity from minor reactions to death and in frequency from infrequent to prevalent.’
sec.gov/Archives/edgar…
@hugodejonge
9/ ‘To date, there has never been a Phase 3 trial for an mRNA-based product or a commercialized mRNA-based product.’
sec.gov/Archives/edgar…
@hugodejonge
10/ Gene therapy
‘Currently, mRNA is considered a gene therapy product by the FDA.’
sec.gov/Archives/edgar…
@hugodejonge
11/ Zo gaat dat in farma-vriendjes-land. @paulpetertak @pfizer @BioNTech_Group @hommel_b @FTM_nl @janheinstrop @hugodejonge
Zie minidraadje:
12/ Draadje in een draadje.
Lezen jullie mee, @paulpetertak @hugodejonge?
13/ ‘[..],none of the vaccine trials are designed to detect a significant reduction in hospital admissions, admission to intensive care, or death.’
bmj.com/content/371/bm…
@hugodejonge
14/ ‘None of the trials currently under way are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths.’
bmj.com/content/371/bm…
@hugodejonge
15/ ‘Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus.’
bmj.com/content/371/bm…
@hugodejonge
16/ Astrazeneca COVID-19 studie protocol
Deelnemers: medisch stabiel bij wie ziekenhuisopname gedurende de studie niet wordt verwacht.
s3.amazonaws.com/ctr-med-7111/D…
@hugodejonge
17/ #Astrazeneca COVID-19 vaccin
Fase 3 onderzoek naar verwachting Valentijnsdag 2023 afgerond.
clinicaltrials.gov/ct2/show/NCT04…
@hugodejonge
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.